37958767|t|Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice.
37958767|a|The interaction of the activating transcription factor 6 (ATF6), a key effector of the unfolded protein response (UPR) in the endoplasmic reticulum, with the neuronal calcium sensor Downstream Regulatory Element Antagonist Modulator (DREAM) is a potential therapeutic target in neurodegeneration. Modulation of the ATF6-DREAM interaction with repaglinide (RP) induced neuroprotection in a model of Huntington's disease. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no cure, characterized by the progressive loss of motoneurons resulting in muscle denervation, atrophy, paralysis, and death. The aim of this work was to investigate the potential therapeutic significance of DREAM as a target for intervention in ALS. We found that the expression of the DREAM protein was reduced in the spinal cord of SOD1G93A mice compared to wild-type littermates. RP treatment improved motor strength and reduced the expression of the ALS progression marker collagen type XIXalpha1 (Col19alpha1 mRNA) in the quadriceps muscle in SOD1G93A mice. Moreover, treated SOD1G93A mice showed reduced motoneuron loss and glial activation and increased ATF6 processing in the spinal cord. These results indicate that the modulation of the DREAM-ATF6 interaction ameliorates ALS symptoms in SOD1G93A mice.
37958767	0	11	Repaglinide	Chemical	MESH:C072379
37958767	20	24	ATF6	Gene	226641
37958767	108	141	activating transcription factor 6	Gene	226641
37958767	143	147	ATF6	Gene	226641
37958767	363	380	neurodegeneration	Disease	MESH:D019636
37958767	400	404	ATF6	Gene	226641
37958767	428	439	repaglinide	Chemical	MESH:C072379
37958767	441	443	RP	Chemical	MESH:C072379
37958767	483	503	Huntington's disease	Disease	MESH:D006816
37958767	505	534	Amyotrophic lateral sclerosis	Disease	MESH:D000690
37958767	536	539	ALS	Disease	MESH:D000690
37958767	546	572	neurodegenerative disorder	Disease	MESH:D019636
37958767	653	671	muscle denervation	Disease	MESH:D019042
37958767	673	680	atrophy	Disease	MESH:D001284
37958767	682	691	paralysis	Disease	MESH:D010243
37958767	824	827	ALS	Disease	MESH:D000690
37958767	962	964	RP	Chemical	MESH:C072379
37958767	1033	1036	ALS	Disease	MESH:D000690
37958767	1056	1079	collagen type XIXalpha1	Gene	12823
37958767	1081	1092	Col19alpha1	Gene	12823
37958767	1240	1244	ATF6	Gene	226641
37958767	1332	1336	ATF6	Gene	226641
37958767	1361	1364	ALS	Disease	MESH:D000690
37958767	1377	1385	SOD1G93A	CellLine	CVCL:C0CZ
37958767	Association	MESH:D000690	226641
37958767	Positive_Correlation	MESH:C072379	226641
37958767	Negative_Correlation	MESH:C072379	MESH:D006816
37958767	Association	MESH:D000690	12823
37958767	Negative_Correlation	MESH:C072379	12823
37958767	Negative_Correlation	MESH:C072379	MESH:D000690

